Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Comorbidities in Mexican Mestizo patients with rheumatoid arthritis: A cross-sectional study of 523 patients in a preventive cardio-rheumatology clinic
Rosa I. Arvizu-Rivera; Jesus A. Cardenas-de la Garza; Valeria Gonzalez-Gonzalez; Dionicio A. Galarza-Delgado; Jose R. Azpiri-Lopez; Andrea L. Guajardo-Aldaco; Maria F. Elizondo-Benitez; Iris J. Colunga-Pedraza;
Reumatol Clin. 2025;21:
Integrating different perspectives to define a concept of comprehensive remission in rheumatoid arthritis: The SUMAR project
Alejandro Balsa; José Luis Andreu; Juan Carlos Hermosa-Hernán; Josefa León-Navarro; Jordi Nicolas Pico; José Javier Pérez Venegas; Susana Romero-Yuste; Raimon Sanmarti; Antonio Ignacio Torralba Gómez-Portillo; Juan Carlos Valenzuela-Gámez; Jordi Cohen;
Reumatol Clin. 2025;21: